The Aspartame Information Service responds to allegations about aspartame
safety published by three anatomists from the Universities of Pretoria and
Limpopo.
The paper by Humphries et al published in the European Journal of Clinical
Nutrition contains no new data about aspartame but rather presents a
distorted review of anecdote and opinion which amounts to nothing more than
scaremongering. Above all, the authors have ignored that aspartame is broken
down by the digestive system to very small quantities of common dietary
components and cannot therefore cause the adverse effects that they
hypothesise.
Aspartame is made from two amino acids or parts of protein, identical to
those found in, for example, meat, cheese, fish, or mothers' milk. The two amino
acids in aspartame are aspartic acid and phenylalanine. We consume these amino
acids in much greater quantities in foods we eat daily as part of our normal
diet. For example, a 220 ml glass of milk contains seven times as much aspartic
acid and more than three times as much phenylalanine as a 330 ml serving of soft
drink sweetened with aspartame alone. A new born baby will obtain more aspartic
acid and phenylalanine from his mother's breast milk every day than there is in
a litre of soft drink sweetened with aspartame. There is more methanol in a
small banana than in a soft drink sweetened with aspartame.
A major review of the science relating to aspartame published in 2007 in
Critical Reviews in Toxicology looked specifically at data relating to
neurology and concluded:
"Studies that mimic human exposure do not show
any evidence of neurological effects. Aspartame is not neurotoxic."
"The data from these studies, in general, do
not support the hypothesis that aspartame in the human diet will affect nervous
system function, learning or behaviour."
"The effect of aspartame on behaviour,
cognitive function, and seizures has been studied extensively in animals,
healthy children, hyperactive children, sugar-sensitive children, healthy
adults, individuals with Parkinson's disease, and individuals suffering from
depression. Overall, the weight of the evidence indicates that aspartame has no
effect on behaviour, cognitive function, neural function, or seizures in any of
these groups."
Furthermore, all of the issues raised in this paper have been considered by
regulatory authorities across the world. In 2002, the European Commission's
Scientific Committee on Food concluded that:
"Aspartame is unique among the intense
sweeteners in that the intake of its component parts can be compared with
intakes of the same substances from natural foods."
At a time when governments and the medical profession are increasingly
concerned about overweight and obesity, it is perverse to raise ill-founded
fears about a popular choice which helps people to control their calorie
in-take. By providing sweetness without calories, aspartame can make a useful
contribution to weight control. For example, a soft drink sweetened with
aspartame can have as little as one Calorie per serving. In Europe alone,
overweight and obesity are estimated to cause 70,000 new cancer cases every
year.
The reason for publication of this article at this point in time remains
obscure. It is noteworthy that the authors do not indicate the source of their
funding for their paper.
3 April, 2008